| Financial Year |
March 31 2023 |
| Monetary Funds |
381,553,774.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
133,060,591.17 |
| Accounts Receivable |
261,908,179.97 |
| Advances to Suppliers |
38,214,857.66 |
| Other Receivables |
3,135,907.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
247,404,065.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,470,749.90 |
| Total Current Assets |
1,173,157,489.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
5,361,845.65 |
| Fixed Assetes |
568,956,548.28 |
| Under-construction Projects |
37,461,712.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,767,097.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,152,457.71 |
| Deferred Income Tax Assets |
13,198,453.76 |
| Other Non-Current Assets |
126,453,022.54 |
| Sub-Total of Non-Current Assets |
767,497,031.34 |
| Total Assets |
1,940,654,520.89 |
| Short-Term Loans |
266,757,155.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,900,000.00 |
| Accounts Payable |
181,648,207.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,181,500.73 |
| Taxes Payable |
5,556,766.38 |
| Interest Payable |
-- |
| Dividend Payable |
472,000.00 |
| Other payables |
16,494,416.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,309,368.89 |
| Other Current Liabilities |
54,823,213.57 |
| Sub-Total of Current Liabilities |
611,567,413.15 |
| Long-term Loans |
1,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,466,185.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,991,583.63 |
| Total Liabilities |
633,558,996.78 |
| Paid-In Capital(Or Share Stock) |
564,369,565.00 |
| Capital Surplus |
841,832,150.04 |
| Surplus Reserve |
69,324,874.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-224,110,375.91 |
| Minority Stockholder's Interest |
60,617,310.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,246,478,213.80 |
| Owner's Equity（Stockholder's Equity） |
1,307,095,524.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,940,654,520.89 |
